Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Tandem Diabetes Care

Explore full profile

Medical devices for the treatment of diabetes offering diabetic insulin pumps for adults and children

San Diego, United StatesFounded 2006Biotech & Life Sciences
Valuation $1.50B Market cap · Aug/2026
Revenue $1.08B Latest reported FY
EBITDA $57M Latest reported FY

At a glance

Founded
2006
Headquarters
San Diego, United States
Listing
IPO 2013
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Latest news

Press, funding announcements and product moves mentioning Tandem Diabetes Care.

See all news

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later4 investors entered at this stage

  • TPG
  • TPG Biotech
  • Domain Associates
  • Delphi Ventures
Employees mapped 2,208 incl. 6 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 33 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
13 countries with
team presence
🇺🇸 United States95.2%
🇨🇦 Canada2.3%
🇨🇭 Switzerland1.4%
🇬🇧 United Kingdom0.2%
🇫🇷 France0.2%
Top 5 of 13 shown
Web traffic by country
400K monthly visits
across markets
🇺🇸 United States62.6%
🇨🇦 Canada11.9%
🇩🇪 Germany8.2%
🇦🇺 Australia2.9%
🇬🇧 United Kingdom2.1%
Top 5 markets shown

Patents

Estimated portfolio value
$108M

171 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Tandem Diabetes Care was the backer or acquirer, 2021–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Tandem Diabetes Care's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Tandem Diabetes Care deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Tandem Diabetes Care's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Tandem Diabetes Care on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Tandem Diabetes Care on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.